Avion Wealth’s Elicio Therapeutics ELTX Stock Holding History

Avion Wealth’s Portfolio ELTX Stock Details ELTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-78	Closed	–	–	1097
2024 Q2	$0	Hold	78	–	–	﹤0.01%	1012
2024 Q1	$1K	Buy	+78	New	+$391	﹤0.01%	915

Other funds holding ELTX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MHC

Meyer Handelman Company Rye Brook, New York $3.22B AUM 24.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Avion Wealth's ELTX Position: Q3 2024 in Review

Avion Wealth sold out of Elicio Therapeutics (ELTX) in Q3 2024, closing a stake of 78 shares.

Avion Wealth first reported a position in ELTX in Q1 2024 and held it in 2 quarters. The position peaked at $1K in Q1 2024. 18 funds tracked by Wall St. Rank hold ELTX as of Q3 2024.

Avion Wealth reported no remaining Elicio Therapeutics position as of Q3 2024 after selling out during the quarter.
Avion Wealth sold 78 Elicio Therapeutics shares in Q3 2024.
Avion Wealth first reported a position in Elicio Therapeutics in Q1 2024 and held it in 2 quarters.
Avion Wealth's Elicio Therapeutics position peaked at $1K in Q1 2024.
18 funds tracked by Wall St. Rank held Elicio Therapeutics as of Q3 2024.

Based on Avion Wealth's 13F filing for Q3 2024, filed 18 Oct 2024.